Expression of Ferroptosis-Related Genes is Correlated with Immune Microenvironment in Diabetic Kidney Disease

References

• Shlisky J, Bloom DE, Beaudreault AR., et al. Nutritional considerations for healthy aging and reduction in age-related chronic disease. Adv Nutrition. 2017;8(1):17–26. doi:10.3945/an.116.013474
   PubMed Web of Science ®Google Scholar
• Cao X, Chen P. The effects of alprostadil combined with α-lipoic acid in the treatment of senile diabetic nephropathy. Am J Transl Res. 2021;13(9):10823–10829.
   Web of Science ®Google Scholar
• Simó R, Ciudin A, Simó-Servat O, Hernández C. Cognitive impairment and dementia: a new emerging complication of type 2 diabetes-The diabetologist’s perspective. Acta Diabetol. 2017;54(5):417–424. doi:10.1007/s00592-017-0970-5
   PubMed Web of Science ®Google Scholar
• Umanath K, Lewis JB. Update on Diabetic Nephropathy: core Curriculum 2018. Am J Kidney Dis. 2018;71(6):884–895. doi:10.1053/j.ajkd.2017.10.026
   PubMed Web of Science ®Google Scholar
• Lin YC, Chang YH, Yang SY, Wu KD, Chu TS. Update of pathophysiology and management of diabetic kidney disease. J Formosan Med Assoc. 2018;117(8):662–675. doi:10.1016/j.jfma.2018.02.007
   PubMed Web of Science ®Google Scholar
• Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032–2045. doi:10.2215/CJN.11491116
   PubMed Web of Science ®Google Scholar
• Lei P, Bai T, Sun Y. Mechanisms of ferroptosis and relations with regulated cell death: a review. Front Physiol. 2019;10:139. doi:10.3389/fphys.2019.00139
   PubMed Web of Science ®Google Scholar
• Kim S, Kang SW, Joo J, et al. Characterization of ferroptosis in kidney tubular cell death under diabetic conditions. Cell Death Dis. 2021;12(2):160. doi:10.1038/s41419-021-03452-x
   PubMed Web of Science ®Google Scholar
• Li S, Zheng L, Zhang J, Liu X, Wu Z. Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy. Free Radic Biol Med. 2021;162:435–449. doi:10.1016/j.freeradbiomed.2020.10.323
   PubMed Web of Science ®Google Scholar
• Feng X, Wang S, Sun Z, et al. Ferroptosis enhanced diabetic renal tubular injury via HIF-1α/HO-1 pathway in db/db mice. Front Endocrinol (Lausanne). 2021;12:626390. doi:10.3389/fendo.2021.626390
   PubMed Web of Science ®Google Scholar
• Navarro-González JF, Mora-Fernández C, Muros de Fuentes M, García-Pérez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol. 2011;7(6):327–340. doi:10.1038/nrneph.2011.51
   PubMed Web of Science ®Google Scholar
• Macisaac RJ, Ekinci EI, Jerums G. Markers of and risk factors for the development and progression of diabetic kidney disease. Am J Kidney Dis. 2014;63(2 Suppl 2):S39–62. doi:10.1053/j.ajkd.2013.10.048
   PubMed Web of Science ®Google Scholar
• Galkina E, Ley K. Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol. 2006;17(2):368–377. doi:10.1681/ASN.2005080859
   PubMed Web of Science ®Google Scholar
• Fernández-Real JM, Vendrell J, García I, Ricart W, Vallès M. Structural damage in diabetic nephropathy is associated with TNF-α system activity. Acta Diabetol. 2012;49(4):301–305. doi:10.1007/s00592-011-0349-y
   Web of Science ®Google Scholar
• Mima A, Qi W, King GL. Implications of treatment that target protective mechanisms against diabetic nephropathy. Semin Nephrol. 2012;32(5):471–478. doi:10.1016/j.semnephrol.2012.07.010
   PubMed Web of Science ®Google Scholar
• Ganz T, Nemeth E. Iron homeostasis in host defence and inflammation. Nat Rev Immunol. 2015;15(8):500–510. doi:10.1038/nri3863
   PubMed Web of Science ®Google Scholar
• Tang B, Zhu J, Li J, et al. The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma. Cell Commun Signal. 2020;18(1):174. doi:10.1186/s12964-020-00663-1
   PubMed Web of Science ®Google Scholar
• Zhang F, Li F, Lu GH, et al. Engineering Magnetosomes for Ferroptosis/Immunomodulation Synergism in Cancer. ACS nano. 2019;13(5):5662–5673. doi:10.1021/acsnano.9b00892
   PubMed Web of Science ®Google Scholar
• Ni L, Yuan C, Zhang C, et al. Co-expression network analysis identified LTF in association with metastasis risk and prognosis in clear cell renal cell carcinoma. Onco Targets Ther. 2020;13:6975–6986. doi:10.2147/OTT.S251000
   PubMed Web of Science ®Google Scholar
• Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572–1573. doi:10.1093/bioinformatics/btq170
   PubMed Web of Science ®Google Scholar
• Wang Y, Peng X, Zhang M, Jia Y, Yu B, Tian J. Revisiting tumors and the cardiovascular system: mechanistic intersections and divergences in ferroptosis. Oxid Med Cell Longev. 2020;2020:9738143. doi:10.1155/2020/9738143
   Web of Science ®Google Scholar
• Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35(6):830–849. doi:10.1016/j.ccell.2019.04.002
   PubMed Web of Science ®Google Scholar
• Ravingerová T, Kindernay L, Barteková M, et al. The molecular mechanisms of iron metabolism and its role in cardiac dysfunction and cardioprotection. Int J Mol Sci. 2020;21:21. doi:10.3390/ijms21217889
   Web of Science ®Google Scholar
• Yang L, Guan G, Lei L, Liu J, Cao L, Wang X. Oxidative and endoplasmic reticulum stresses are involved in palmitic acid-induced H9c2 cell apoptosis. Biosci Rep. 2019;39:5. doi:10.1042/BSR20190225
   Web of Science ®Google Scholar
• Ma B, Guan G, Lv Q, Yang L. Curcumin ameliorates palmitic acid-induced Saos-2 cell apoptosis via inhibiting oxidative stress and autophagy. Evid Based Complement Alternat Med. 2021;2021:5563660. doi:10.1155/2021/5563660
   Web of Science ®Google Scholar
• Betjes MG, Langerak AW, van der Spek A, de Wit EA, Litjens NH. Premature aging of circulating T cells in patients with end-stage renal disease. Kidney Int. 2011;80(2):208–217. doi:10.1038/ki.2011.110
   PubMed Web of Science ®Google Scholar
• Costa E, Lima M, Alves JM, et al. Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. J Clin Immunol. 2008;28(3):268–275. doi:10.1007/s10875-007-9168-x
   Web of Science ®Google Scholar
• Borges A, Borges M, Fernandes J, et al. Apoptosis of peripheral CD4(+) T-lymphocytes in end-stage renal disease patients under hemodialysis and rhEPO therapies. Ren Fail. 2011;33(2):138–143. doi:10.3109/0886022X.2011.553300
   PubMed Web of Science ®Google Scholar
• Jailwala P, Waukau J, Glisic S, et al. Apoptosis of CD4+ CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation. PLoS One. 2009;4(8):e6527. doi:10.1371/journal.pone.0006527
   Web of Science ®Google Scholar
• Meyers JH, Chakravarti S, Schlesinger D, et al. TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation. Nat Immunol. 2005;6(5):455–464. doi:10.1038/ni1185
   Web of Science ®Google Scholar
• Pichler R, Afkarian M, Dieter BP, Tuttle KR. Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets. Am J Physiol Renal Physiol. 2017;312(4):F716–f731. doi:10.1152/ajprenal.00314.2016
   PubMed Web of Science ®Google Scholar
• Moon JY, Jeong KH, Lee TW, Ihm CG, Lim SJ, Lee SH. Aberrant recruitment and activation of T cells in diabetic nephropathy. Am J Nephrol. 2012;35(2):164–174. doi:10.1159/000334928
   PubMed Web of Science ®Google Scholar
• Zeng C, Shi X, Zhang B, et al. The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J Mol Med. 2012;90(2):175–186. doi:10.1007/s00109-011-0816-5
   PubMed Web of Science ®Google Scholar
• Yatim N, Jusforgues-Saklani H, Orozco S, et al. RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells. Science. 2015;350(6258):328–334. doi:10.1126/science.aad0395
   PubMed Web of Science ®Google Scholar
• Martin-Sanchez D, Ruiz-Andres O, Poveda J, et al. Ferroptosis, but not necroptosis, is important in nephrotoxic folic acid-induced AKI. J Am Soc Nephrol. 2017;28(1):218–229. doi:10.1681/ASN.2015121376
   PubMed Web of Science ®Google Scholar
• Fang X, Wang H, Han D, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci U S A. 2019;116(7):2672–2680. doi:10.1073/pnas.1821022116
   PubMed Web of Science ®Google Scholar
• Vinten-Johansen J, Jiang R, Reeves JG, Mykytenko J, Deneve J, Jobe LJ. Inflammation, proinflammatory mediators and myocardial ischemia-reperfusion Injury. Hematol Oncol Clin North Am. 2007;21(1):123–145. doi:10.1016/j.hoc.2006.11.010
   PubMed Web of Science ®Google Scholar
• Boag SE, Andreano E, Spyridopoulos I. Lymphocyte communication in myocardial ischemia/reperfusion injury. Antioxid Redox Signal. 2017;26(12):660–675. doi:10.1089/ars.2016.6940
   PubMed Web of Science ®Google Scholar
• Sha W, Hu F, Xi Y, Chu Y, Bu S. Mechanism of ferroptosis and its role in type 2 diabetes mellitus. J Diabetes Res. 2021;2021:9999612. doi:10.1155/2021/9999612
   PubMed Web of Science ®Google Scholar
• Wu K, Fei L, Wang X, et al. ZIP14 is involved in iron deposition and triggers ferroptosis in diabetic nephropathy. Metallomics. 2022;14(7). doi:10.1093/mtomcs/mfac034
   Web of Science ®Google Scholar
• Jin T, Chen C. Umbelliferone delays the progression of diabetic nephropathy by inhibiting ferroptosis through activation of the Nrf-2/HO-1 pathway. Food Chem Toxicol. 2022;163:112892. doi:10.1016/j.fct.2022.112892
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Jiang X, Gu W. Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol. 2020;30(6):478–490. doi:10.1016/j.tcb.2020.02.009
   PubMed Web of Science ®Google Scholar
• Xu Z, Peng B, Liang Q, et al. Construction of a ferroptosis-related nine-lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma. Front Immunol. 2021;12:719175. doi:10.3389/fimmu.2021.719175
   PubMed Web of Science ®Google Scholar
• Zhang K, Ping L, Du T, et al. A ferroptosis-related lncRNAs signature predicts prognosis and immune microenvironment for breast cancer. Front Mol Biosci. 2021;8:678877. doi:10.3389/fmolb.2021.678877
   PubMed Web of Science ®Google Scholar
• Wen Q, Liu J, Kang R, Zhou B, Tang D. The release and activity of HMGB1 in ferroptosis. Biochem Biophys Res Commun. 2019;510(2):278–283. doi:10.1016/j.bbrc.2019.01.090
   PubMed Web of Science ®Google Scholar
• Yu Y, Xie Y, Cao L, et al. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol Cell Oncol. 2015;2(4):e1054549. doi:10.1080/23723556.2015.1054549
   PubMed Web of Science ®Google Scholar
• Yamazaki T, Hannani D, Poirier-Colame V, et al. Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists. Cell Death Differ. 2014;21(1):69–78. doi:10.1038/cdd.2013.72
   PubMed Web of Science ®Google Scholar
• Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19(7):405–414. doi:10.1038/s41568-019-0149-1
   PubMed Web of Science ®Google Scholar